![MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY](https://touchoncology.com/wp-content/uploads/sites/2/2020/12/Fig-2-1.jpg)
MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY
![Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations - Journal of Thoracic Oncology Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ed5a2e9f-c0b8-45d1-a6f9-48d800e5943c/gr1.jpg)
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations - Journal of Thoracic Oncology
![MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer Identified by Anchored Multiplex PCR and Next- Generation Sequencing MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer Identified by Anchored Multiplex PCR and Next- Generation Sequencing](https://www.primescholars.com/articles-images/cancer-epidemiology-prevention-Integrated-Genome-Viewer-1-1-1-g001a.png)
MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer Identified by Anchored Multiplex PCR and Next- Generation Sequencing
![Frontiers | Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study | Oncology Frontiers | Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study | Oncology](https://www.frontiersin.org/files/Articles/649766/fonc-11-649766-HTML/image_m/fonc-11-649766-g001.jpg)
Frontiers | Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study | Oncology
![The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - ScienceDirect The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0305737220300608-gr3.jpg)
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - ScienceDirect
![A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations - Santarpia - Translational Lung Cancer Research A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations - Santarpia - Translational Lung Cancer Research](https://cdn.amegroups.cn/journals/pbpc/files/journals/5/articles/49717/public/49717-PB5-3767-R1.png/w300)
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations - Santarpia - Translational Lung Cancer Research
![Detection of MET Exon 14 Skipping Alterations in Lung Cancer Clinical Samples Using a PCR-Based Approach | SpringerLink Detection of MET Exon 14 Skipping Alterations in Lung Cancer Clinical Samples Using a PCR-Based Approach | SpringerLink](https://media.springernature.com/original/springer-static/image/chp%3A10.1007%2F978-1-0716-1278-1_11/MediaObjects/474110_1_En_11_Fig2_HTML.png)
Detection of MET Exon 14 Skipping Alterations in Lung Cancer Clinical Samples Using a PCR-Based Approach | SpringerLink
![Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration | Nature Medicine Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-019-0716-8/MediaObjects/41591_2019_716_Fig1_HTML.png)
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration | Nature Medicine
![MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY](https://touchoncology.com/wp-content/uploads/sites/2/2020/12/Fig-1-1.jpg)
MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY
![Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non–small-cell Lung Cancer - Clinical Lung Cancer Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non–small-cell Lung Cancer - Clinical Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/df0dbf25-b023-4553-9f6b-87905379ae01/gr1.jpg)
Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non–small-cell Lung Cancer - Clinical Lung Cancer
![MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer Identified by Anchored Multiplex PCR and Next- Generation Sequencing MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer Identified by Anchored Multiplex PCR and Next- Generation Sequencing](https://www.primescholars.com/articles-images/cancer-epidemiology-prevention-FusionPlex-assay-data-1-1-1-g001b.png)
MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer Identified by Anchored Multiplex PCR and Next- Generation Sequencing
![Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients - ScienceDirect Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1556086418330387-gr2.jpg)
Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients - ScienceDirect
![DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer - Journal of Thoracic Oncology DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3eafbcbf-f53b-4a20-aa8b-c0a33c9f5c5c/gr1_lrg.jpg)
DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer - Journal of Thoracic Oncology
![The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable - ScienceDirect The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S016950021630527X-gr2.jpg)